Saadou Issifou

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

Emmanuel B. Bache, Sélidji Todagbé Agnandji, Bertrand Lell et al. · The Lancet · 2015 · 671 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +16

Fosmidomycin for malaria

Michel A. Missinou, Steffen Borrmann, Andreas Schindler et al. · The Lancet · 2002 · 221 citations

First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria

Benjamin Mordmüller, Mihály Sulyok, Diane Egger‐Adam et al. · Clinical Infectious Diseases · 2019 · 158 citations · Full text

Veterinary Medicine, Infectious Diseases, Maternal Health +17

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Kwaku Poku Asante, Salim Abdulla, Sélidji Todagbé Agnandji et al. · The Lancet Infectious Diseases · 2011 · 136 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

Fosmidomycin‐Clindamycin for the Treatment of<i>Plasmodium falciparum</i>Malaria

Steffen Borrmann, Saadou Issifou, Gilbert Esser et al. · The Journal of Infectious Diseases · 2004 · 134 citations

Pharmacy, Infectious Diseases, Pharmacology +17